{"id":"https://openalex.org/A5032577689","orcid":"https://orcid.org/0000-0002-9113-5538","observed_orcids":["https://orcid.org/0000-0002-9113-5538"],"display_name":"Haixiang Cao","raw_author_names":["H. Cao","Hai-Xiang Cao","Haixiang Cao","Hai\u2010Xiang Cao"],"full_name":"Haixiang Cao","works_count":13,"cited_by_count":482,"summary_stats":{"2yr_mean_citedness":4.8,"h_index":8,"i10_index":7},"ids":{"openalex":"https://openalex.org/A5032577689","orcid":"https://orcid.org/0000-0002-9113-5538","observed_orcids":["https://orcid.org/0000-0002-9113-5538"]},"affiliations":[{"institution":{"id":"https://openalex.org/I200296433","ror":"https://ror.org/02drdmm93","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},"years":[2009]},{"institution":{"id":"https://openalex.org/I4387155163","ror":"https://ror.org/04b1hsx72","display_name":"Shenzhen Chipscreen Biosciences Co.","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]},"years":[2025,2023,2021,2019,2016,2012,2009]}],"last_known_institutions":[{"id":"https://openalex.org/I4387155163","ror":"https://ror.org/04b1hsx72","display_name":"Shenzhen Chipscreen Biosciences Co.","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387155163"]}],"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","count":8,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","count":7,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","count":5,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":9.21e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","value":8.41e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":5.04e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","value":2.27e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9315775632858276},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.8031015396118164},{"id":"2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","score":0.7263056039810181},{"id":"90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","score":0.6942000389099121},{"id":"134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","score":0.6070070266723633}],"counts_by_year":[{"year":2009,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":1,"oa_works_count":0,"cited_by_count":4},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":9},{"year":2016,"works_count":2,"oa_works_count":1,"cited_by_count":17},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":15},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":28},{"year":2019,"works_count":1,"oa_works_count":1,"cited_by_count":25},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":39},{"year":2021,"works_count":2,"oa_works_count":2,"cited_by_count":59},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":48},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":45},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":45},{"year":2025,"works_count":5,"oa_works_count":2,"cited_by_count":66},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":67}],"display_name_alternatives":["H. Cao","Hai-Xiang Cao","Haixiang Cao","Hai\u2010Xiang Cao"],"block_key":"h cao","works_api_url":"https://api.openalex.org/works?filter=author.id:A5032577689","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5032577689","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}